UnitedHealth Group Stock Rating Reaffirmed by TheStreet (UNH)
UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating restated by TheStreet in a research note issued on Friday, StockRatingsNetwork reports.
The analysts wrote, “UnitedHealth Group (UNH) has been reiterated by TheStreet Ratings as a buy with a ratings score of A. The company’s strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.”
UnitedHealth Group (NYSE:UNH) traded down 0.50% during mid-day trading on Friday, hitting $71.80. 557,482 shares of the company’s stock traded hands. UnitedHealth Group has a 52 week low of $51.09 and a 52 week high of $75.88. The stock has a 50-day moving average of $72.76 and a 200-day moving average of $65.64. The company has a market cap of $72.999 billion and a price-to-earnings ratio of 13.74.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 18th. The company reported $1.40 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.25 by $0.15. The company had revenue of $30.40 billion for the quarter, compared to the consensus estimate of $30.48 billion. During the same quarter in the previous year, the company posted $1.27 earnings per share. The company’s revenue for the quarter was up 11.5% on a year-over-year basis.
Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group (NYSE:UNH) from $70.00 to $80.00 in a research note to investors on Tuesday. They now have an “overweight” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of UnitedHealth Group (NYSE:UNH) in a research note to investors on Monday, September 16th. They now have a $78.00 price target on the stock. Finally, analysts at Raymond James raised their price target on shares of UnitedHealth Group (NYSE:UNH) from $70.00 to $82.00 in a research note to investors on Tuesday, July 23rd. They now have a “strong-buy” rating on the stock. Three analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $75.94.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.